These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12781097)

  • 1. [Iron overload. More than hereditary hemochromatosis].
    Altés Hernández A
    Med Clin (Barc); 2003 May; 120(18):704-6. PubMed ID: 12781097
    [No Abstract]   [Full Text] [Related]  

  • 2. Hereditary hemochromatosis and its elusive natural history.
    McDonnell SM; Parrish RG
    Arch Intern Med; 2003 Nov; 163(20):2421-3; author reply 2427. PubMed ID: 14609775
    [No Abstract]   [Full Text] [Related]  

  • 3. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundamentals of the laboratory diagnosis in inherited hemochromatosis (literature survey)].
    Kazanets EG; Karamian NA
    Klin Lab Diagn; 2004 Oct; (10):7-13. PubMed ID: 15584392
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mutation of H-ferritin gene in a family associated with hereditary iron overload: a new iron overload-related gene?].
    Kato J
    Rinsho Ketsueki; 2001 May; 42(5):403-7. PubMed ID: 11452460
    [No Abstract]   [Full Text] [Related]  

  • 6. Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: the HEmochromatosis FAmily Study.
    Jacobs EM; Hendriks JC; van Deursen CT; Kreeftenberg HG; de Vries RA; Marx JJ; Stalenhoef AF; Verbeek AL; Swinkels DW
    J Hepatol; 2009 Jan; 50(1):174-83. PubMed ID: 19008010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
    Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
    Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive factors of response to erytrhocytapheresis in patients with biochemical iron overload with or without hereditary hemochromatosis type 1].
    Parra Salinas I; Montes Limon A; Recasens Flores V; Fernandez-Mosteirin N; Garcia-Erce JA
    Med Clin (Barc); 2014 Mar; 142(5):187-91. PubMed ID: 24041941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis.
    Fonseca PFS; Cançado RD; Naoum FA; Dinardo CL; Fonseca GHH; Gualandro SFM; Krieger JE; Pereira AC; Brissot P; Santos PCJL
    BMC Med Genet; 2018 Jan; 19(1):3. PubMed ID: 29301508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of screening for hemochromatosis.
    Dubois S; Kowdley KV
    Arch Intern Med; 2003 Nov; 163(20):2424-6; author reply 2426. PubMed ID: 14609776
    [No Abstract]   [Full Text] [Related]  

  • 12. [Differential diagnosis in hyperferritinemia].
    Olesnicki M
    Rev Med Brux; 2000 Dec; 21(6):A517-9. PubMed ID: 11194503
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary atherosclerosis and body iron stores.
    Auer J; Berent R; Weber T; Eber B
    J Am Coll Cardiol; 2003 May; 41(10):1848-9; author reply 1849-50. PubMed ID: 12767679
    [No Abstract]   [Full Text] [Related]  

  • 14. Dual diagnoses of hereditary hyperferritinaemia-cataract syndrome and hereditary haemochromatosis.
    Hughes M; Vosylius P
    Clin Lab Haematol; 2006 Oct; 28(5):357-9. PubMed ID: 16999731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dysmetabolic iron overload syndrome is clinically and genetically distinct from HFE-related genetic hemochromatosis.
    Rovati A; Bergamaschi G; Casula S; Cerani P; Grasso M; Cazzola M
    Haematologica; 1999 Feb; 84(2):182-3. PubMed ID: 10091420
    [No Abstract]   [Full Text] [Related]  

  • 16. HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload.
    Remacha AF; Carrasco M; Sardá MP; Barceló MJ; Baiget M
    Haematologica; 1999 Mar; 84(3):284-5. PubMed ID: 10189401
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemochromatosis heterozygotes may have significant iron overload when they also have hereditary spherocytosis.
    Mohler DN; Wheby MS
    Am J Med Sci; 1986 Nov; 292(5):320-4. PubMed ID: 3777017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixture models of serum iron measures in population screening for hemochromatosis and iron overload.
    McLaren CE; Li KT; McLaren GD; Gordeuk VR; Snively BM; Reboussin DM; Barton JC; Acton RT; Dawkins FW; Harris EL; Eckfeldt JH; Moses GC; Adams PC
    Transl Res; 2006 Oct; 148(4):196-206. PubMed ID: 17002922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and diagnostic testing for hemochromatosis and iron overload.
    Adams PC
    Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.